PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,928 | +232.7% | 2,703 | +334.6% | 0.00% | +200.0% |
| Q2 2023 | $24,924 | +52929.8% | 622 | -46.1% | 0.00% | 0.0% |
| Q1 2023 | $47 | -38.2% | 1,153 | -41.7% | 0.00% | -66.7% |
| Q4 2022 | $76 | -100.0% | 1,978 | -45.5% | 0.00% | 0.0% |
| Q3 2022 | $193,000 | -71.7% | 3,627 | -69.1% | 0.00% | -80.0% |
| Q2 2022 | $683,000 | +11.1% | 11,723 | +45.6% | 0.02% | +150.0% |
| Q1 2022 | $615,000 | -25.2% | 8,053 | -41.1% | 0.01% | -57.1% |
| Q4 2021 | $822,000 | +1687.0% | 13,666 | +1560.5% | 0.01% | +1300.0% |
| Q3 2021 | $46,000 | -89.2% | 823 | -88.3% | 0.00% | -90.9% |
| Q2 2021 | $427,000 | +107.3% | 7,045 | +139.5% | 0.01% | +266.7% |
| Q1 2021 | $206,000 | -15.2% | 2,942 | -27.8% | 0.00% | -57.1% |
| Q4 2020 | $243,000 | +341.8% | 4,072 | +343.6% | 0.01% | +600.0% |
| Q3 2020 | $55,000 | -72.9% | 918 | -76.3% | 0.00% | -87.5% |
| Q2 2020 | $203,000 | +109.3% | 3,872 | +51.8% | 0.01% | +14.3% |
| Q3 2019 | $97,000 | +54.0% | 2,551 | +77.6% | 0.01% | +75.0% |
| Q2 2019 | $63,000 | +472.7% | 1,436 | +414.7% | 0.00% | +300.0% |
| Q1 2019 | $11,000 | +1000.0% | 279 | +1368.4% | 0.00% | – |
| Q1 2018 | $1,000 | -97.2% | 19 | -97.6% | 0.00% | -100.0% |
| Q4 2017 | $36,000 | -87.0% | 797 | -89.1% | 0.01% | -78.3% |
| Q3 2017 | $276,000 | +5420.0% | 7,335 | +7235.0% | 0.02% | +2200.0% |
| Q2 2017 | $5,000 | 0.0% | 100 | -16.0% | 0.00% | – |
| Q1 2017 | $5,000 | -28.6% | 119 | -47.8% | 0.00% | -100.0% |
| Q4 2016 | $7,000 | -91.1% | 228 | -90.1% | 0.00% | -87.5% |
| Q3 2016 | $79,000 | -60.5% | 2,313 | -61.0% | 0.01% | -57.9% |
| Q2 2016 | $200,000 | +412.8% | 5,936 | +713.2% | 0.02% | +216.7% |
| Q1 2016 | $39,000 | +387.5% | 730 | +588.7% | 0.01% | +500.0% |
| Q4 2015 | $8,000 | -83.7% | 106 | -91.2% | 0.00% | -80.0% |
| Q3 2015 | $49,000 | +2350.0% | 1,198 | +4507.7% | 0.01% | – |
| Q2 2015 | $2,000 | -75.0% | 26 | -71.4% | 0.00% | -100.0% |
| Q4 2014 | $8,000 | -65.2% | 91 | -62.2% | 0.00% | -66.7% |
| Q3 2014 | $23,000 | +187.5% | 241 | +167.8% | 0.00% | +200.0% |
| Q2 2014 | $8,000 | -91.8% | 90 | -94.6% | 0.00% | -93.8% |
| Q4 2013 | $97,000 | +185.3% | 1,682 | +136.9% | 0.02% | +300.0% |
| Q3 2013 | $34,000 | +54.5% | 710 | -4.7% | 0.00% | +100.0% |
| Q2 2013 | $22,000 | – | 745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |